Michael Strebl
Overview
Explore the profile of Michael Strebl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liaci A, Chandra N, Vodnala S, Strebl M, Kumar P, Pfenning V, et al.
PLoS Pathog
. 2025 Jan;
21(1):e1012892.
PMID: 39883726
Human adenovirus type 36 (HAdV-D36) has been putatively linked to obesity in animals and has been associated with obesity in humans in some but not all studies. Despite extensive epidemiological...
2.
Strebl M, Arache A, Blech M, Bakowsky U, Garidel P
Eur J Pharm Sci
. 2024 Oct;
203:106924.
PMID: 39426179
Protein formulations may form proteinaceous particles that vary in size from nanometers to millimeters. Monitoring the kinetics of protein particle formation, e.g., through accelerated degradation studies, is an attempt to...
3.
Dos Santos Natividade R, Dumitru A, Nicoli A, Strebl M, Sutherland D, Welsh O, et al.
Nanoscale Horiz
. 2024 Sep;
9(11):1925-1937.
PMID: 39347978
Understanding the mechanisms underlying viral entry is crucial for controlling viral diseases. In this study, we investigated the interactions between reovirus and Nogo-receptor 1 (NgR1), a key mediator of reovirus...
4.
Sutherland D, Strebl M, Koehler M, Welsh O, Yu X, Hu L, et al.
Proc Natl Acad Sci U S A
. 2023 Jun;
120(24):e2219404120.
PMID: 37276413
Nogo-66 receptor 1 (NgR1) binds a variety of structurally dissimilar ligands in the adult central nervous system to inhibit axon extension. Disruption of ligand binding to NgR1 and subsequent signaling...
5.
Hiemenz C, Pacios-Michelena A, Helbig C, Vezocnik V, Strebl M, Nikels F, et al.
J Pharm Sci
. 2023 May;
112(8):2190-2202.
PMID: 37211315
Characterization of particulate impurities such as aggregates is necessary to develop safe and efficacious adeno-associated virus (AAV) drug products. Although aggregation of AAVs can reduce the bioavailability of the virus,...
6.
Rath D, Rapp V, Schwartz J, Winter S, Emschermann F, Arnold D, et al.
JACC Basic Transl Sci
. 2022 Jun;
7(5):445-461.
PMID: 35663628
Genetic predisposition through single-nucleotide variation (SNV) influences circulatory soluble junctional adhesion molecule-A (sJAM-A) levels in coronary artery disease (CAD) patients. Homozygous carriers of the minor alleles (SNVs rs2774276, rs790056) show...
7.
Persson B, John L, Rafie K, Strebl M, Frangsmyr L, Ballmann M, et al.
Proc Natl Acad Sci U S A
. 2021 Jan;
118(3).
PMID: 33384338
Human adenovirus species D (HAdV-D) types are currently being explored as vaccine vectors for coronavirus disease 2019 (COVID-19) and other severe infectious diseases. The efficacy of such vector-based vaccines depends...
8.
Rustmeier N, Strebl M, Stehle T
Viruses
. 2019 Oct;
11(10).
PMID: 31615155
Virus infections are initiated by the attachment of the viral particle to protein or carbohydrate receptors on the host cell. Sialic acid-bearing glycan structures are prominently displayed at the cell...
9.
Sun G, Strebl M, Merz M, Blamberg R, Huang F, McGraphery K, et al.
Plant J
. 2019 May;
100(1):20-37.
PMID: 31124249
Enzyme promiscuity, a common property of many uridine diphosphate sugar-dependent glycosyltransferases (UGTs) that convert small molecules, significantly hinders the identification of natural substrates and therefore the characterization of the physiological...